Skip to content

A Study on the Laser Therapy for Involuting Hemangiomas

A Study on the Efficacy and Safety of Combined Laser Therapy for Involuting Hemangiomas: A Prospective, Self-Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126019
Enrollment
Unknown
Registered
2026-06-02
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile hemangiomas and congenital hemangiomas.

Interventions

Experimental group:Fractional CO2 laser + PDL/Long pulsed 1064 laser

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >= 6 months; 2. Diagnosis of involuting infantile hemangioma or congenital hemangioma (post-involution), with visible red patches, telangiectasia, and/or irregular skin surface requiring laser intervention; 3. The legal guardian of the subject voluntarily participates in this study and provides written informed consent; 4. The legal guardian of the subject is able to comply with the requirements of the study protocol and cooperate in completing the follow-up.

Exclusion criteria

Exclusion criteria: 1. The hemangioma is in the rapid proliferation phase; 2. The lesion site has active infection or ulceration; 3. Previous treatment of the target lesion area with laser, surgery, or systemic medication (such as propranolol) that may affect the evaluation in this study (as judged by the investigator); 4. History of photosensitive diseases or being in a photosensitive state; 5. History of keloid formation.

Design outcomes

Primary

MeasureTime frame
Global Aesthetic Improvement Scale(GAIS);

Secondary

MeasureTime frame
Lesion color, texture, thickness, and composite score;Adverse Events;Overall Satisfaction Score (VAS Scale);

Countries

China

Contacts

Public ContactLin Xiaoxi

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

linxiaoxi@126.com+86 137 0199 7136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026